GlassScriptPhysician profile
Barbara A Wagner
NPI 1578675666
$1,019.94
in general payments reported to CMS, 2019-2025
12 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $43.39 · 2023: $413 · 2024: $110 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $215.07 | 2021 | |
| Boston Scientific Corporation | $183.16 | 2025 | Axios |
| Abbvie INC. | $123.26 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.76 | 2022-2024 | Jardiance |
| Idorsia Pharmaceuticals US INC | $108.57 | 2023 | Quviviq |
| Daiichi Sankyo INC. | $98.67 | 2023 | Injectafer |
| Lilly USA, LLC | $80.91 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $22.14 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $20.73 | 2023 | |
| Glaxosmithkline, LLC. | $18.80 | 2022 | |
| Hologic Sales and Service, LLC | $18.62 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.25 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.